Covid-19 vaccine in children age five to 11. “We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12 (sic)," Pfizer wrote on Twitter.
UPDATE: We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12.
pic.twitter.com/72Z2HXlkOx "We're committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat," Pfizer said.
The company had said earlier in September that its Covid vaccine was found to be safe and produced a robust immune response in children aged 5-11 in Phase 2/3 trials.